Raia Drogasil S.A. Sponsored ADR (RADLY)
OTC
Closed
Oct 9, 2026
Day's Range
4.1552 wk Range
3.10Overview - RADLY - Raia Drogasil S.A. Sponsored ADR
Key Statistics
Valuation
Enterprise Value
2.64B
P/E (Trailing)
‪19.52‬
P/E (Forward)
‪14.43‬
PEG Ratio
‪1.24‬
Price / Sales (TTM)
‪0.12‬
Price / Book
‪4.14‬
EV / EBITDA
‪3.57‬
Profitability
Gross Margin
‪33.42%‬
Profit Margin
‪2.88%‬
Operating Margin
‪7.58%‬
Return on Assets
‪7.79%‬
Return on Equity
‪19.99%‬
Ownership
Shares Outstanding
1.74B
Float
1.31B
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.0010%‬
Price stats
Beta
‪0.02‬
50-Day Avg
‪3.67‬
200-Day Avg
‪4.16‬
Dividends
Payout Ratio
‪48.59%‬
Frequency
Quarterly
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - RADLY - Raia Drogasil S.A. Sponsored ADR
Peers - RADLY - Raia Drogasil S.A. Sponsored ADR
Peer Comparison
Compared with companies in Pharmaceutical Retailers listed on OTC.
- RADLYOTCRaia Drogasil S.A. Sponsored ADR6.57BMarket Cap+7.18%52-week change19.53P/E (Trailing)‪2.88%‬Profit Margin
- JDHIYOTCJD Health International Inc. - ADR16.10BMarket Cap-79.80%52-week change17.41P/E (Trailing)‪7.86%‬Profit Margin
- TSUSFOTCTsuruha Holdings Inc.7.81BMarket Cap+36.23%52-week change22.40P/E (Trailing)‪2.48%‬Profit Margin
- ALBHFOTCAlibaba Health Information Technology Ltd.5.88BMarket Cap-141.48%52-week change17.95P/E (Trailing)‪5.65%‬Profit Margin
- MSMKFOTCMatsukiyoCocokara & Co.5.85BMarket Cap-28.13%52-week change16.72P/E (Trailing)‪5.09%‬Profit Margin
- SGIPFOTCSugi Holdings Co., Ltd.3.53BMarket Cap+14.22%52-week change11.44P/E (Trailing)‪2.96%‬Profit Margin
- SDGCFOTCSundrug Co., Ltd.3.29BMarket Cap+0.00%52-week change17.40P/E (Trailing)‪3.70%‬Profit Margin
Profile Summary - RADLY - Raia Drogasil S.A. Sponsored ADR
About
Raia Drogasil S.A. Sponsored ADR represents shares of Raia Drogasil, a leading pharmaceutical retail company based in Brazil, available to investors in the United States. This American Depositary Receipt allows U.S. investors to participate in the Brazilian pharmaceutical retail market without the need to directly…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
